BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19668109)

  • 1. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
    Hara S; Umino D; Someya T; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T
    Pediatr Res; 2009 Nov; 66(5):524-7. PubMed ID: 19668109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats.
    Endo A; Someya T; Nakagawa M; Murano Y; Sakuraya K; Hara S; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T
    Pediatr Res; 2014 Jan; 75(1-1):38-44. PubMed ID: 24121426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats.
    Kim JH; Lee YH; Lim BJ; Jeong HJ; Kim PK; Shin JI
    Sci Rep; 2016 Mar; 6():22374. PubMed ID: 26947764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.
    Young BA; Burdmann EA; Johnson RJ; Alpers CE; Giachelli CM; Eng E; Andoh T; Bennett WM; Couser WG
    Kidney Int; 1995 Aug; 48(2):439-48. PubMed ID: 7564111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity.
    Li C; Yang CW; Ahn HJ; Kim WY; Park CW; Park JH; Cha JH; Kim J; Kim YS; Bang BK
    Nephron; 2002 Oct; 92(2):422-30. PubMed ID: 12218323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
    Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast attenuates chronic cyclosporine nephrotoxicity in rats.
    Tao Y; Hu L; Li S; Bai Y; Liu Q; Jin Y; Wei D; Luo Z
    Transplant Proc; 2009 Dec; 41(10):4373-5. PubMed ID: 20005402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
    Satyanarayana PS; Chopra K
    Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy.
    Duymelinck C; Deng JT; Dauwe SE; De Broe ME; Verpooten GA
    Kidney Int; 1998 Sep; 54(3):804-18. PubMed ID: 9734605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
    Li C; Yang CW; Kim WY; Jung JY; Cha JH; Kim YS; Kim J; Bennett WM; Bang BK
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F389-98. PubMed ID: 12529276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
    Hagar HH; El Etter E; Arafa M
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.
    Olukman M; Can C; Coşkunsever D; Uyanikgil Y; Çavuşoğlu T; Sözmen E; Duman S; Çelenk FG; Ülker S
    Adv Clin Exp Med; 2019 Oct; 28(10):1393-1401. PubMed ID: 31518496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
    Thomas SE; Andoh TF; Pichler RH; Shankland SJ; Couser WG; Bennett WM; Johnson RJ
    Kidney Int; 1998 Apr; 53(4):897-908. PubMed ID: 9551396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
    Li C; Sun BK; Lim SW; Song JC; Kang SW; Kim YS; Kang DH; Cha JH; Kim J; Yang CW
    Transplantation; 2005 Jun; 79(11):1522-9. PubMed ID: 15940041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone alters the histopathology of chronic cyclosporine nephropathy.
    Stillman IE; English J; Burdmann EA; Andoh TF; Franschini N; Bennett WM; Rosen S
    Exp Nephrol; 1997; 5(1):61-8. PubMed ID: 9052850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of an antioxidant tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity].
    Shi S; Zheng S; Jia C; Zhu Y; Xie H
    Zhonghua Wai Ke Za Zhi; 2002 Sep; 40(9):709-12. PubMed ID: 12411148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity.
    Mizui M; Isaka Y; Takabatake Y; Mizuno S; Nakamura T; Ito T; Imai E; Hori M
    Kidney Int; 2004 Jun; 65(6):2041-53. PubMed ID: 15149317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.